Clinical Trial Update: A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating early Zidovudine (AZT) treatment in asymptomatic HIV-infected infants; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED